Redeye comments on Teneo AI’s Q2, showing flat underlying q/q ARR growth.
Redeye comments on Teneo AI’s Q2 report showing negative q/q ARR growth, but, on the other hand, a strong development of the pipeline.
Redeye retains its positive view of Teneo AI despite a Q1 report on the soft side.
Redeye comments on Teneo AI’s Q1 report showing a flat SaaS ARR q/q – weaker than we expected – but an encouraging increase in the new sales...
Redeye strengthens its positive view of Teneo AI following a Q4 report with substantially accelerating q/q SaaS ARR growth.
Redeye comments on Teneo AI’s Q4, aligning strong preliminary figures showing a rapid acceleration in SaaS ARR.
Redeye takes a positive stance on Teneo AI raising SEK60m from a directed share issue.
Redeye strengthens its positive view of Teneo AI following preliminary Q4 figures showing a substantial increase in SaaS ARR growth.
Redeye strengthens its positive view of Teneo AI following a Q3 report with substantially accelerating q/q SaaS ARR growth.
Redeye takes a more positive stance on Teneo AI following the Q3 report showing accelerating SaaS ARR growth.
Redeye sees a Q2 report roughly matching our expectations.
Redeye sees a stable Q2 report from Teneo AI, with solid customer intake being the highlight.
Redeye comments on Artificial Solutions' directed rights issue, which was announced after the market closed on June 19 and completed before ...
Redeye updates its estimates on Artificial Solutions, which continues to grow strongly, underpinned by exceptional upsell on existing custom...
Redeye provides a brief comment on Artificial Solutions' Q1 2024 report, which closely aligns with our sales target and EBITDA-Capex estimat...
Redeye comments today's news about the collaboration with MedHelp Care, which operates one of the most used health platforms for employers i...
Redeye updates its estimates following Artificial Solutions' Q4 2023 report.
Redeye comments on Artificial Solutions' Q4 2023 report, which showed a total ARR of SEK63m and a SaaS ARR of SEK31m, growing by 31% and 24%...
Redeye comments on Artificial Solution's announcement of the outcome of the rights issue.
Redeye comments on Artificial Solutions’ rights issue of SEK25.
Redeye updates its view on Artificial Solutions (AS) on the back of its Q3 2023 report.
Redeye comments on Artificial Solutions (AS) Q3’2023 report.
Redeye comments on Artificial Solutions ARR numbers for August.
Redeye updates its view on Artificial Solutions on the back its Q2 2023 report, where ARR and recurring revenues continue to grow, although ...
Redeye comments on Artificial Solutions Q2’2023 report.
Redeye updates its estimates and valuation on the back of the Q1 2023 report, where ARR and recurring revenues came in stronger than expecte...
Redeye comments on Artificial Solutions Q1’23 report.
Redeye updates its estimates and valuation on the back of the Q4 2022 report and recent right issue.
Redeye comments on Aritificial Solutions Q4’22 report.
Redeye comments on Artificial Solutions’ rights issue and updated terms with its debt provider.
Redeye raises its estimates on the back of a strong Q3 2022 report, which beat expectations and provided some bullish financial targets.
Redeye views Artificial Solutions’ Q3 2022 results in a positive light.
Redeye sees some near-term challenges: growing operating losses and a looming capital raise.
Redeye has a positive take on Artificial Solutions’ SaaS metrics, which grew impressively in Q2 2022, and have continued to do so in July 20...
Redeye maintains its fair value range unchanged – the quarterly financials were in line with expectations.
Redeye has a positive initial take on the Q1 report – SaaS KPIs confirm that Artificial Solutions is progressing according to plan.
Redeye lowers its fair value range as we soften near term sales expectations – we expect 16% growth this year.
Redeye will likely make slight estimate changes on the back of Artificial Solutions' year-end report.
Redeye has a positive take on the recent Microsoft partnership and reiterates its Base Case.
Redeye lowers its Base Case after reviewing Artificial’s Q2 report.
Redeye's initial take includes softer sales than forecast, yielding a larger than expected operating loss.
